Blog

A: Enzyme-Linked Immunosorbent Assay (ELISA) is a classical immunoassay technology that relies on antigen-antibody specific binding, immobilizing soluble antigens/antibodies on solid-phase microplates, and utilizes signal amplification through enzyme-catalyzed substrate chromogenic reactions for qualitative and quantitative detection of trace substances in biological samples. This technology features high sensitivity, strong specificity, low sample consumption, and high-throughput detection capability, widely used in clinical pathogen detection, tumor marker screening, and autoantibody detection; in scientific research, it is used for quantitative detection of cytokines, antigens, antibodies, and other biomolecules.

A: Mainly two points: ① Core experimental objective: distinguish whether quantitative detection of content is needed, or analysis of substance biological activity. ELISA is more suitable for quantitative detection of concentration; if detecting biological activities such as protein catalytic activity or binding activity, ELISA alone is insufficient and needs to be combined with other functional assays. ② Target information: For protein and peptide targets, it is recommended to query the Uniprot ID (unique protein identifier) in the Uniprot database, and cross-check the kit indicator name with the Uniprot ID during selection; when homologous proteins or splice isoforms exist, the ID can precisely lock onto the target molecule to avoid selection errors.

A: ① Predict target concentration range: Review literature, reference past data, or conduct pilot experiments to estimate the approximate target concentration in samples. For low target concentrations, prioritize high-sensitivity kits; for high target concentrations, conventional sensitivity kits can be used while considering the detection range. ② Confirm sample compatibility: Check the kit instructions or consult the manufacturer to confirm that the kit supports your sample type; understand sample pretreatment requirements and the kit's anti-interference capability to prevent sample matrix interference from distorting results.

A: Sensitivity refers to the lowest concentration of target substance that a kit can detect, determining the kit's ability to detect low-abundance targets.
When target concentration is low, prioritize high-sensitivity kits to prevent false negatives; when target concentration is at conventional levels, select a kit with appropriate sensitivity based on experimental needs and cost.

A: Specificity represents the ability of kit antibodies to bind only to the target, with the core evaluation indicator being the cross-reactivity rate; the lower the cross-reactivity rate, the better the specificity. High-quality kit antibodies should avoid cross-reactivity with homologous family proteins, homologous molecules from different species, serum interfering factors, and target-interacting proteins. During selection, review the cross-reactivity validation data in the instructions; this is especially important when the target has homologous proteins to reduce false-positive risks.

A: Precision (reproducibility) represents the consistency of results from multiple tests of the same sample, expressed as the coefficient of variation (CV), divided into intra-plate precision and inter-plate precision. Industry standard: both intra-plate and inter-plate CV ≤10%.

A: Accuracy reflects the degree of conformity between kit detection results and the true concentration of the sample, verified by spike recovery rate.
Operation summary: Add gradient standards to known concentration natural sample matrix, use unspiked samples as blank controls, calculate the percentage of measured values to theoretical added values after detection. Acceptable kit recovery rate is 80%-120%; the closer to 100%, the higher the accuracy. Abnormal recovery rates indicate matrix interference or antibody binding deviation, prone to false positives/negatives, and should be selected with caution.

A: Linearity refers to the proportional relationship between the detected concentration and the true sample concentration, ensuring accurate quantification of both high and low concentration samples.
Validation method: Add standards to natural matrix to prepare gradient diluted samples, plot standard curves after detection, and calculate the correlation coefficient R²; R² typically needs to be greater than 0.99 to ensure data reliability and accuracy of the linear relationship, while spike recovery rates at each gradient need to be maintained at 80%-120%. Failure to meet linearity standards will cause detection result distortion.

A: ① High-quality kits: All performance parameters meet standards, verified through multiple batches and clinical sample testing. Suitable for high-level scientific research, clinical diagnosis, and other experiments requiring high detection precision. ② Conventional quality kits: Meet basic research performance at lower prices. Suitable for routine qualitative and semi-quantitative experiments, as well as pilot experiments. Selection should comprehensively consider experimental objectives, precision requirements, and budget, balancing experimental quality and cost.

A: No. ELISA excels at detecting target content and concentration; for detecting biological activities such as enzyme catalytic activity or protein binding activity, other functional assay methods are needed, and ELISA alone cannot complete activity analysis.

A: Prioritize querying the target gene ID; when purchasing kits, in addition to checking the indicator name, the gene ID labeled on the kit must be verified; simultaneously review the cross-reactivity data in the instructions to confirm that the kit antibodies do not recognize homologous isoforms, avoiding detection of non-target molecules.